Equity Research, Broker Reports, and media content on AstraZeneca PLC

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about AstraZeneca PLC
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

AstraZeneca PLC

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on AstraZeneca PLC. We currently have 290 research reports from 11 professional analysts.

  • Open: 9806p
  • Range Today: 9667/9836p
  • 52 Week: 8090/11540p
  • Daily Volume: 1.7m
  • Daily Liquidity: 0.11%
  • # Shares: 1,549m
  • Market Cap: £151,719m
  • Latest PE (hist): 79.43
  • Div Yield: 2.14
Date Source Announcement
03Oct22 15:00 RNS AstraZeneca PLC - Total Voting Rights
30Sep22 10:30 RNS AstraZeneca PLC - Board Committee Changes
27Sep22 07:05 RNS AstraZeneca PLC - Koselugo approved in Japan for NF1
27Sep22 07:00 RNS AstraZeneca PLC - Tezspire approved in Japan for severe asthma
23Sep22 07:00 RNS AstraZeneca PLC - Ultomiris approved in EU for gMG
22Sep22 07:00 RNS AstraZeneca PLC - Lynparza approved in China for ovarian cancer
21Sep22 07:00 RNS AstraZeneca PLC - Tezspire approved in the EU for severe asthma
  • Frequency of research reports


  • Research reports on

    AstraZeneca PLC

  • Providers covering

    AstraZeneca PLC